Satoh T - Search Results

1

Therapeutic targets for metastatic prostate cancer.

Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Timme TL, et al. Among authors: satoh t. Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127. Curr Drug Targets. 2003. PMID: 12643475 Review.

2

Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, Thompson TC. Tahir SA, et al. Among authors: satoh t. Cancer Res. 2001 May 15;61(10):3882-5. Cancer Res. 2001. PMID: 11358800

3

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA, Thompson TC. Li L, et al. Among authors: satoh t. Cancer Res. 2001 Jun 1;61(11):4386-92. Cancer Res. 2001. PMID: 11389065

4

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.

Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, Yang G, Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, Wheeler TM, Butler EB, Kadmon D, Thompson TC. Miles BJ, et al. Among authors: satoh t. Hum Gene Ther. 2001 Nov 1;12(16):1955-67. doi: 10.1089/104303401753204535. Hum Gene Ther. 2001. PMID: 11686937 Clinical Trial.

5

In situ gene therapy for prostate cancer: immunomodulatory approaches.

Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: satoh t. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.

6

The role of caveolin-1 in androgen insensitive prostate cancer.

Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Mouraviev V, et al. Among authors: satoh t. J Urol. 2002 Oct;168(4 Pt 1):1589-96. doi: 10.1016/S0022-5347(05)64526-0. J Urol. 2002. PMID: 12352463 Review.

7

Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.

Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC. Satoh T, et al. Cancer. 2003 Mar 1;97(5):1225-33. doi: 10.1002/cncr.11198. Cancer. 2003. PMID: 12599229 Free article.

8

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.

Satoh T, Timme TL, Saika T, Ebara S, Yang G, Wang J, Ren C, Kusaka N, Mouraviev V, Thompson TC. Satoh T, et al. Hum Gene Ther. 2003 Jan 20;14(2):91-101. doi: 10.1089/104303403321070793. Hum Gene Ther. 2003. PMID: 12614561

9

Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis.

Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, Kadmon D, Cai WW, Chinault AC, Boone TB, Bradley A, Thompson TC. Cao G, et al. Among authors: satoh t. Am J Pathol. 2003 Apr;162(4):1241-8. doi: 10.1016/S0002-9440(10)63920-X. Am J Pathol. 2003. PMID: 12651616 Free PMC article.

10

Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.

Satoh T, Saika T, Ebara S, Kusaka N, Timme TL, Yang G, Wang J, Mouraviev V, Cao G, Fattah el MA, Thompson TC. Satoh T, et al. Cancer Res. 2003 Nov 15;63(22):7853-60. Cancer Res. 2003. PMID: 14633713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,807 results

Search Page

Filters